{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:42Z","timestamp":1793608002595,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129168","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:54:57Z","timestamp":1790081697000},"page":"129168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000\u20132019"],"prefix":"10.1016","volume":"92","author":[{"given":"Nick","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erjola","family":"Hani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jeffery-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.vaccine.2026.129168_bb0005","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"issue":"8949","key":"10.1016\/j.vaccine.2026.129168_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps\/rubella vaccines","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.129168_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/adc.84.3.227","article-title":"B. Idiopathic thrombocytopenic purpura and MMR vaccine","volume":"84","author":"Miller","year":"2001","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129168_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2026.129168_bb0025","doi-asserted-by":"crossref","unstructured":"Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev;11(11):CD004407. doi:https:\/\/doi.org\/10.1002\/14651858.CD004407.pub5.","DOI":"10.1002\/14651858.CD004407.pub5"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129168_bb0030","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.vaccine.2006.10.054","article-title":"NOPHO ITP working group and five national study groups. Vaccination associated thrombocytopenic purpura in children","volume":"25","author":"Rajantie","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129168_bb0035","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.vaccine.2020.01.090","article-title":"Assessment of pre-specified adverse events following varicella vaccine: a population-based self-controlled risk interval study","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129168_bb0040","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1542\/peds.2014-1822","article-title":"Safety of measles-containing vaccines in 1-year-old children","volume":"135","author":"Klein","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.129168_bb0045","first-page":"15","article-title":"MMR vaccine and idiopathic thrombocytopenic purpura","volume":"27","author":"Committee on safety of medicines and the medicines control agency","year":"2001","journal-title":"Curr Probl Pharmacovigil"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129168_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/adc.2007.126003","article-title":"Idiopathic thrombocytopenic purpura and the second dose of MMR","volume":"93","author":"Stowe","year":"2008","journal-title":"Arch Dis Child"},{"issue":"13","key":"10.1016\/j.vaccine.2026.129168_bb0060","article-title":"Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety datalink","volume":"4","author":"Hanson","year":"2023","journal-title":"Vaccine X"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129168_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O\u2019Leary","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129168_bb0070","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2025-070931","article-title":"Risk of immune thrombocytopenic purpura recurrence following second measles-containing vaccine dose","volume":"156","author":"Zerbo","year":"2025","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129168_bb0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.62.4.567","article-title":"Thrombocytopenic purpura related to rubella infection","volume":"62","author":"Ozsoylu","year":"1978","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129168_bb0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/jcm10040877","article-title":"Thrombocytopenia in virus infections","volume":"10","author":"Raadsen","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129168_bb0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:34:57Z","timestamp":1793604897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":16,"alternative-id":["S0264410X26009771"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129168","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000\u20132019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129168"}}